Combination of serum and peritoneal 1.3-beta-d-glucan can rule out intra-abdominal candidiasis in surgical critically ill patients: a multicenter prospective study

BACKGROUND: Intra-abdominal candidiasis (IAC) is difficult to predict in critically ill patients with intra-abdominal infection, leading to the overuse of antifungal treatments. Serum and peritoneal 1.3-beta-d-glucan (sBDG and pBDG) have been proposed to confirm or invalidate the diagnosis of IAC, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Novy, Emmanuel, Rivière, Jérémie, Nguyen, Maxime, Arfeuille, Gaëlle, Louis, Guillaume, Bouhemad, Bélaïd, Pottecher, Julien, Hecketsweiler, Stéphane, Germain, Adeline, Laithier, François-Xavier, Losser, Marie-Reine, Debourgogne, Anne, Bernard, Yohann, Rousseau, Hélène, Baumann, Cédric, Luc, Amandine, Birckener, Julien, Machouart, Marie-Claire, Guerci, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691030/
https://www.ncbi.nlm.nih.gov/pubmed/38037130
http://dx.doi.org/10.1186/s13054-023-04761-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691030/
https://www.ncbi.nlm.nih.gov/pubmed/38037130
http://dx.doi.org/10.1186/s13054-023-04761-7

Ejemplares similares